Five-day course of oral antiviral appears to stop SARS-CoV-2 in its tracksMarch 9, 2021COVID-19 Updates
Tocilizumab (Actemra) scores FDA approval for systemic sclerosis–associated interstitial lung diseaseMarch 5, 2021Pulmonology